| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.3M | +41.7% |
| Cost of Revenue | $23.7M | +19.5% |
| Gross Profit | $7.6M | +236.9% |
| R&D Expense | $5.2M | -39.1% |
| SG&A Expense | $26.3M | -26.4% |
| Operating Income | -$31.8M | +36.7% |
| Pre-tax Income | -$34.1M | +37.2% |
| Income Tax | -$36K | -495.2% |
| Net Income | -$44.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.5M | -57.3% |
| Short-term Investments | $6K | -99.9% |
| Accounts Receivable | $3.3M | -49.7% |
| Inventory | $24.0M | -45.3% |
| Current Assets | $65.9M | -37.2% |
| Total Assets | $132.6M | -28.6% |
| Current Liabilities | $29.1M | -0.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.4M | +63.5% |
| Capital Expenditures | $846K | -88.9% |
| Investing Cash Flow | $4.1M | +124.8% |
| Financing Cash Flow | $1.2M | +102.6% |
| Free Cash Flow | -$22.2M | +66.4% |
| +17.2% |
| EPS (Basic) | -$1.45 | +18.5% |
| EPS (Diluted) | -$1.45 | +18.5% |
| Long-term Debt |
| $362K |
| — |
| Total Liabilities | $54.6M | -14.2% |
| Stockholders' Equity | $77.8M | -36.1% |